For millions of Americans, even if they have health insurance and prescription medication coverage (but especially if they don’t), expensive and unaffordable prescription pharmaceuticals have become an awful fact of life. Restasis, made by Allergan, is one of a lengthy list of prescription medications whose prices have skyrocketed in recent years. Take, for example, the Restasis prescription eye medication. So, why are these medications so expensive?
This question, it turns out, has a solution. Even better, there are a couple of methods to save money on Restasis right now. Continue reading to find out more.
Firstly, Know About What is Restasis?
Cyclosporine is the active ingredient in Restasis. Cyclosporine is an immunosuppressive medication used to aid organ transplant recipients. It prevents the new organ from being rejected by the patient’s body. Cyclosporine is used to treat hyperactive immune responses in different ways. Psoriasis and rheumatoid arthritis, for example, are treated with cyclosporine.
Restasis is a medication that is used to treat persistent dry eyes. Inflammation is the underlying cause of chronic dry eye in certain persons. Inflamed tissues can affect the lacrimal glands, which are responsible for the production of tears. Patients’ eyes get dry and itchy when their lacrimal glands stop working. Chronic dry eye has a significant detrimental impact on patients’ quality of life. It also affects vision.
Restasis eye drops are used to treat this problem. Patients who use Restasis can administer cyclosporine directly to their eyes twice a day.
In the United States, how much does Restasis cost?
Restasis costs $586 per month on a wholesale basis in the United States. That works out to almost $7,032 each year. Prices, however, vary. Patients’ actual medicine costs are influenced by their insurance coverage and pharmacy discounts. In addition, retail prices are usually greater than wholesale prices.
Restasis has an average retail price of $729.74. Medicare Part D patients may have to pay $42. They may, however, have to pay more than $640.
Few reasons why Restasis costs so much in the US:
A lack of oversight by the government
Drug prices are set or regulated by the federal government in some countries. In the United States, however, this is not the case.
Insurance companies are unable to bargain.
There is no single federal health insurance system in the United States. Instead, Americans purchase health insurance from a variety of private companies. Each insurance company has a meeting with pharmaceutical companies. Then it tries to negotiate the drug’s price to keep costs low for its recipients. Regrettably, insurance companies do not have much negotiating power. If a pharmaceutical business disagrees with the price of a drug, an insurance company can refuse to cover it.
However, if even one insurer agrees to cover the drug at a high cost, the other insurers lose their bargaining power. Americans will choose the insurer that covers the drug they desire if the other insurers walk away from the table.
Insurance businesses are easy to conquer since they are competitively divided. In essence, pharmaceutical businesses are free to determine their rates.
Struggles in the US Government’s Negotiations
The federal government does not have the authority to determine medicine pricing unilaterally. It can, however, bargain on behalf of Medicare and Medicaid.
Unfortunately, these attempts have also been impeded.
Medicare and Medicaid, in principle, serve as conduits between drug makers and patients. Because drug companies cannot afford to lose business, government negotiators have room to walk away from the table.
In practice, however, federal rules mandate that all FDA-approved pharmaceuticals be covered by Medicaid and Medicare. Negotiations between government departments are hampered as a result of this. Even if they didn’t have this handicap, federal negotiators might not try very hard to lower drug prices. This is because pharmaceutical firms employ lobbyists. These lobbyists use convincing arguments–and campaign contributions–to persuade Congress members to oppose corporate profit restrictions.
Putting Profit First in Marketing
Profit is a top priority for pharmaceutical businesses. Increasing demand is one approach to creating money. This is made possible by marketing.
Regrettably, marketing is also costly. In fact, in 2020, pharmaceutical corporations will spend $6.58 billion on direct-to-consumer advertising. Spending money on marketing is a risk. The corporation intends to repay the costs by increasing medicine sales.
If each drug has a bigger profit margin, this is easier to accomplish. If a drug’s profit margin is high, the manufacturer doesn’t need to sell as many units to cover its costs.
Marketing costs incentivize bigger profit margins in this way. As a result, drug prices rise.
Manipulation of Patent Law
Every drug’s price is driven up by poor government negotiations and marketing costs. Restasis, in particular, exposes how firms manipulate patent rules to boost drug prices.
Monopolies can be formed as a result of this manipulation. Monopolies eliminate competition to avoid competitive pricing.
Patent terms can last decades, making it nearly impossible for customers to find more affordable alternatives. If that wasn’t terrible enough, slight changes to a drug’s composition or delivery mechanism can be enough to qualify for a patent extension or new patent, further suffocating competition.
Patent dodging
Allergan went to even greater lengths to protect Restasis, one of its most popular and profitable medications, from the competition. Allergen forged an unprecedented deal with the St. Regis Mohawk tribe in New York State to avoid what is already a loose patent regulation system in the United States, surprising and alarming even some of the most cynical pharmaceutical industry watchdogs and critics.
Tribes like the St. Regis Mohawk are exempt from and operate outside of federal jurisdictions in the United States, including patent rules, because they are sovereign nations. Allergan gave the tribe its Restasis patents, which are set to expire in 2024, and agreed to pay them licensing fees and a percentage of profits as a way to avoid patent challenges and generic dry eye medication competition.
Allergan’s attempts to shield themselves from US patent law ultimately failed, and they were defeated in several court rulings, which were settled by the US Supreme Court when it refused to hear the case, leaving the lower court rulings in place.
They may have lost that particular battle, but it demonstrates the lengths pharmaceutical firms would go to maintain market control and limit competition to protect their profits in the United States.
How to Make Your Restasis Prescription Cost Less?
Dry eyes can be bothersome and even have an impact on a person’s productivity and quality of life, making contact lenses difficult to use and creating light sensitivity. As more people spend more time in front of screens than ever before, issues like the chronic dry eye will almost certainly become more widespread.
With over 40% of Americans unable to pay $400 in an emergency, and millions of people lately losing their employer-sponsored health insurance owing to unemployment due to the coronavirus epidemic, $600+ for a monthly supply of Restasis can be nearly hard to buy.
Many prescriptions have manufacturer coupons and assistance programs that can provide large discounts in some situations, but there are no guarantees and many patients do not qualify. Always check with the manufacturer and individual insurance plans for rebates and assistance programs that can help you save money on your medications.
Purchase Restasis for a Lower Price Today
“Why is Restasis so expensive?” is a question we can answer. But, even better, we can provide you with alternatives.
LifeRx Pharmacy is an online pharmacy. We’re prepared to bring you the meds you require at a reasonable cost. Using our safe and secure online ordering system, you can obtain any prescription medication.
FAQ:
Is there a cheaper alternative to Restasis?
Are you curious as to why Restasis is so costly? The cost of healthcare is a complicated subject. The exorbitant price of Restasis, on the other hand, serves as a case study in price inflation.
Restasis is, after all, based on the medication cyclosporine. Since the 1970s, cyclosporine has been used. Restasis was approved for the first time in 1983.
Astagraf XL® is a newer cyclosporine version. Organ transplant recipients are prescribed it by doctors. The acquisition cost of the lowest Astragraf XL® dosage was $72.76 in 2021.
Another company, Imprimis Pharmaceuticals plans to make its cyclosporine-based formulations available as customizable and potentially low-cost alternatives to Restasis, a dry eye medication. The company hopes that by offering lower-cost alternatives, more patients will have access to a high-quality cyclosporine treatment option.
Initial prescriptions will cost 99 cents for a one-month supply, with refills starting at $79 per month. Imprimis also intends to provide a presentation about its fully-owned business Surface Pharmaceuticals, which specializes in ocular surface illnesses like dry eye and blepharitis.
What does Restasis do for your eyes?
Restasis is an immunosuppressive medicine that helps to prevent additional injury by reducing inflammation in the tear glands. After using this drug for a long time, some patients report that their tear production has improved. It’s crucial to remember, however, that your Restasis medication may take several weeks to develop a therapeutic effect, and it could take up to 6 months to get the full benefit. Some patients say they stopped using Restasis eye drops because they didn’t think they were working right. Restasis, on the other hand, is used to prevent future damage to your tear glands, not to generate tears or dampness in your eyes.
Is there a generic for Restasis in the USA?
The first Restasis generic, cyclosporine eye drops, was authorized by the FDA in February 2022. These eye drops are just as safe and effective as their name-brand counterparts.
While an exact price has yet to be announced, it is believed to be less than what customers have been paying for the brand in the past. When you go to fill your next Restasis prescription, ask your pharmacist if they’ve started receiving shipments of generic cyclosporine eye drops.
Efforts to improve competition and lower drug prices include supporting the development and expanding opportunities to bring complex generic drugs to market.
Is there a generic alternative for Restasis?
In February 2022, The FDA approved Cyclosporine eye drops for one specific use: persistent dry eye. Dry eye disease (DED) or Keratoconjunctivitis Sicca are other names for this condition. This generic Restasis is approved for the same uses as the brand-name Restasis. As a result, both drugs would be recommended to treat the same ailment.
How can I pay less for Restasis?
Restasis has a generic counterpart that is available worldwide and can be a cost-effective alternative to purchasing Restasis online as a brand-name medicine. The cost of Restasis varies based on factors such as the type of insurance you have, manufacturer rebates and discounts, and where the prescription is eventually filled due to a lack of pricing restrictions or government oversight and regulation.
Make use of a manufacturer’s coupon or a government-sponsored patient aid program. Allergan offers a savings card that can help patients save up to $300 on Restasis, as well as a patient assistance program that can allow qualified patients to acquire Restasis for free.
Use a coupon. Patients can save at least 15% on the full retail price of Restasis with a coupon.
Make enough for a 90-day supply. It’s possible that filling a 90-day supply (rather than a 30-day supply) will save you money on this prescription. You’ll also spend less time and money at the drugstore because you’ll make fewer excursions.
If your health insurance and your plan exclude Restasis, talk to your doctor about filing an appeal. Some insurance plans demand prior permission, which means you may need to acquire insurance coverage approval before filling your prescription. If you have health insurance, contact your provider for more details.
How much does Restasis cost without insurance?
Restasis costs $586 per month on a wholesale basis in the United States. That works out to almost $7,032 each year. Prices, however, vary. Patients’ actual medicine costs are influenced by their insurance coverage and pharmacy discounts. In addition, retail prices are usually greater than wholesale prices.
Pingback: Why Is The USA Healthcare System So Expensive